ICONIC LABS PLC — AGM Information 2023

Aug 25, 2023

National Storage Mechanism | Additional information

RNS Number : 5191K

Iconic Labs PLC

25 August 2023

25 August 2023

Iconic Labs PLC

("Iconic" or the "Company")

Result of AGM

Iconic Labs PLC (LSE: ICON) is pleased to announce that at the Company's Annual General Meeting ('AGM') held at 3pm today, all resolutions were duly passed by way of poll.

At the meeting, inter alia, a resolution was passed which approved the consolidation of the Company's ordinary shares on a 10,000 for 1 basis, such that every 10,000 ordinary shares of £0.00001 each were consolidated into 1 ordinary share of £0.1 in nominal value.

As a result, the Company's existing issued share capital of 46,996,580,000 ordinary shares of £0.00001 was consolidated into 4,699,658 ordinary shares of £0.1, each with one voting right.  Admission in respect of such new ordinary shares will become effective and that dealings in those new ordinary shares will commence on 30 August 2023. As a result of the consolidation, the ISIN of the ordinary shares will change from GB00BD060S65 to GB00BRBJ3P08.

The above figure of 4,699,658 should be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

The results of the poll were as follows: 

	Resolutions	For	%	Against	%	Withheld
1	To receive and adopt the accounts for the financial year ended 30 June 2021.	6,029,829,160	99.02	59,851,506	0.98	89,879,728
2	To receive and adopt the accounts for the financial year ended 30 June 2022.	6,029,829,160	99.02	59,851,506	0.98	89,879,728
3	To re-appoint Norden Audit Limited as Auditors.	6,021,542,347	98.66	81,671,752	1.34	76,346,295
4	To authorise the Directors to determine the remuneration of the Auditors.	6,000,845,301	98.32	102,368,798	1.68	76,346,295
5	To re-appoint Bradley Tyler Taylor as a Director.	6,024,039,929	98.76	75,405,149	1.24	80,115,316
6	To re-appoint David Štýbr as a Director.	6,014,911,904	98.61	84,533,174	1.39	80,115,316
7	To re-appoint Marija Hrebac as a Director.	6,004,365,470	98.44	95,079,608	1.56	80,115,316
8	To re-appoint Emmanuel Blouin as a Director.	5,994,271,904	98.28	105,173,174	1.72	80,115,316
9	Issued ordinary share capital be consolidated and divided into 4,699,658 ordinary shares of £0.1 each.	5,910,559,957	96.84	192,654,142	3.16	76,346,295
10	To authorise the Directors to allot shares up to a maximum aggregate nominal amount of £1,905,217.39.	6,012,800,530	98.52	90,413,569	1.48	76,346,295
	Special Resolutions:
11	To empower the Directors to generally allot relevant equity securities under Resolution 10.	6,010,800,530	98.49	92,413,569	1.50	76,346,295
12	To authorise the Directors to make market purchases of own shares.	6,039,251,219	98.95	63,962,880	1.04	76,346,295

A vote withheld is not a vote in law and is not counted in the calculation of the percentage of shares voted for or against any resolution.

- Ends -

For more information, please contact:

Iconic Labs Brad Taylor, Chief Executive Officer	Tel: +44 (0) 7462 156238
Novum Securities Limited David Coffman / Daniel Harris	Tel: +44 (0) 20 7399 9400
Yellow Jersey PR Sarah Hollins Annabelle Wills Bessie Elliot	Tel: +44 (0) 20 3004 9512 iconic@yellowjerseypr.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGPPUMCRUPWGAA